Iterum Therapeutics (ITRM) Earnings (2017 - 2025)
Iterum Therapeutics (ITRM) earnings from Jun 30, 2017 to Sep 30, 2025. The TTM Iterum Therapeutics (ITRM) earnings is -$45M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Iterum Therapeutics (ITRM) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +47.79% |
| 3 Years TTM | +1.23% |
| 5 Years TTM | -6.87% |
| All Time TTM | +3.14% |
Annual Earnings change of Iterum Therapeutics (ITRM)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$20M | -17.72% |
| 2024 | -$25M | -35.44% |
| 2023 | -$38M | -13.64% |
| 2022 | -$44M | -51.47% |
| 2021 | -$92M | +76.04% |
| 2020 | -$52M | -49.57% |
| 2019 | -$103M | +33.83% |
| 2018 | -$77M | +162.02% |
| 2017 | -$29M | +118.50% |
| 2016 | -$13M | N/A |
Comparison Iterum Therapeutics (ITRM) five years earnings CAGR with competitors
Iterum Therapeutics (ITRM) five years earnings CAGR is -6.87%.